Qualys (NASDAQ:QLYS – Get Free Report) had its price target upped by stock analysts at TD Cowen from $130.00 to $150.00 in a report issued on Wednesday, Benzinga reports. The brokerage presently has a “hold” rating on the software maker’s stock. TD Cowen’s price objective would indicate a potential upside of 16.98% from the company’s current price.
Several other equities research analysts have also recently issued reports on the stock. Wedbush dropped their target price on shares of Qualys from $190.00 to $160.00 and set an “outperform” rating on the stock in a report on Wednesday, August 7th. Scotiabank decreased their price target on shares of Qualys from $167.00 to $150.00 and set a “sector perform” rating on the stock in a research report on Wednesday, August 7th. Truist Financial decreased their price target on shares of Qualys from $130.00 to $120.00 and set a “hold” rating on the stock in a research report on Wednesday, October 23rd. UBS Group decreased their price target on shares of Qualys from $170.00 to $140.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. Finally, Morgan Stanley lifted their target price on shares of Qualys from $123.00 to $126.00 and gave the company an “underweight” rating in a research note on Wednesday. Three research analysts have rated the stock with a sell rating, twelve have assigned a hold rating, one has given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $146.00.
Check Out Our Latest Stock Analysis on Qualys
Qualys Trading Up 2.9 %
Qualys (NASDAQ:QLYS – Get Free Report) last issued its earnings results on Tuesday, August 6th. The software maker reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.32 by $0.20. Qualys had a net margin of 29.36% and a return on equity of 44.80%. The company had revenue of $148.70 million for the quarter, compared to analysts’ expectations of $148.80 million. During the same quarter last year, the company posted $0.95 earnings per share. The firm’s quarterly revenue was up 8.4% on a year-over-year basis. As a group, equities analysts predict that Qualys will post 3.94 earnings per share for the current year.
Insider Activity at Qualys
In related news, CFO Joo Mi Kim sold 616 shares of the company’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $123.54, for a total transaction of $76,100.64. Following the transaction, the chief financial officer now directly owns 86,576 shares in the company, valued at approximately $10,695,599.04. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Qualys news, CFO Joo Mi Kim sold 616 shares of the company’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $123.54, for a total value of $76,100.64. Following the transaction, the chief financial officer now directly owns 86,576 shares in the company, valued at $10,695,599.04. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Bruce K. Posey sold 1,339 shares of the company’s stock in a transaction dated Monday, October 21st. The stock was sold at an average price of $123.56, for a total transaction of $165,446.84. Following the completion of the transaction, the insider now owns 55,279 shares in the company, valued at $6,830,273.24. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 10,919 shares of company stock worth $1,360,140. Insiders own 1.00% of the company’s stock.
Hedge Funds Weigh In On Qualys
A number of hedge funds have recently added to or reduced their stakes in the stock. Aigen Investment Management LP purchased a new stake in shares of Qualys in the 3rd quarter worth approximately $445,000. State of New Jersey Common Pension Fund D lifted its position in shares of Qualys by 14.5% in the 3rd quarter. State of New Jersey Common Pension Fund D now owns 15,851 shares of the software maker’s stock worth $2,036,000 after purchasing an additional 2,010 shares during the period. Legacy Capital Wealth Partners LLC purchased a new stake in shares of Qualys in the 3rd quarter worth approximately $224,000. Covestor Ltd lifted its position in shares of Qualys by 19.7% in the 3rd quarter. Covestor Ltd now owns 1,177 shares of the software maker’s stock worth $151,000 after purchasing an additional 194 shares during the period. Finally, Tandem Investment Advisors Inc. lifted its position in shares of Qualys by 1.0% in the 3rd quarter. Tandem Investment Advisors Inc. now owns 32,851 shares of the software maker’s stock worth $4,220,000 after purchasing an additional 326 shares during the period. 99.31% of the stock is currently owned by institutional investors.
Qualys Company Profile
Qualys, Inc, together with its subsidiaries, provides cloud-based platform delivering information technology (IT), security, and compliance solutions in the United States and internationally. It offers Qualys Cloud Apps, which include Cybersecurity Asset Management and External Attack Surface Management; Vulnerability Management, Detection and Response; Web Application Scanning; Patch Management; Custom Assessment and Remediation; Multi-Vector Endpoint Detection and Response; Context Extended Detection and Response; Policy Compliance; File Integrity Monitoring; and Qualys TotalCloud, as well as Cloud Workload Protection, Cloud Detection and Response, Cloud Security Posture Management, Infrastructure as Code, and Container Security.
Featured Stories
- Five stocks we like better than Qualys
- What is MarketRank™? How to Use it
- 2 Alternative Internet Stocks Staging a Breakout in 2024
- Quiet Period Expirations Explained
- Discover the 3 Best-Performing Biotech IPO Stocks of 2024
- What is a Low P/E Ratio and What Does it Tell Investors?
- Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
Receive News & Ratings for Qualys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qualys and related companies with MarketBeat.com's FREE daily email newsletter.